Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Redeemable Preferred Stock And Shareholders' Equity (Deficit)

v3.24.1
Consolidated Statements Of Redeemable Preferred Stock And Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series J Convertible Redeemable Preferred Stock
Series H Convertible Redeemable Preferred Stock
Series F Convertible Preferred Stock
Common Stock
Common Stock
Series J Convertible Redeemable Preferred Stock
Common Stock
Series H Convertible Redeemable Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series E Convertible Preferred Stock
Additional Paid-in Capital
Series J Convertible Redeemable Preferred Stock
Additional Paid-in Capital
Series H Convertible Redeemable Preferred Stock
Additional Paid-in Capital
Series F Convertible Preferred Stock
Convertible Preferred Stock
Series F Convertible Preferred Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Mezzanine Equity
Series J Convertible Redeemable Preferred Stock
Mezzanine Equity
Series I Preferred Stock
Mezzanine Equity
Series H Convertible Redeemable Preferred Stock
Mezzanine Equity
Series F Convertible Preferred Stock
Mezzanine Equity
Series G Preferred Stock
Balance at Dec. 31, 2020 $ 10,028             $ 261,671             $ (251,376)       $ 118  
Balance, shares at Dec. 31, 2020         39,000                              
Balance, shares at Dec. 31, 2020                                     1,000  
Conversion of Convertible Securities                 $ 13,291     $ 630 $ (630)              
Conversion of convertible preferred stock, shares                         (1,000)              
Sale of common stock, net 13,291                                      
Sale of common stock, net, shares       1,000 6,000                              
Exercise of stock options, net $ 132             132                        
Exercise of stock options, net, shares [1] 0                                      
Issuance of common stock for settlement of liability $ 510             510                        
Issuance of Restricted Shares 164             164                        
Stock-based compensation 2,416             2,416                        
Deemed dividend on convertible preferred stock       $ 500               (546) $ 546              
Issuance of stock from RSUs, net, share         2,000                              
Deemed dividend on convertible preferred stock (546)                                      
Conversion of convertible preferred stock                 $ 13,291     630 $ (630)              
Stock Issued During Period, Shares, Conversion of Convertible Securities                         (1,000)              
Exercise of common stock warrants 15,063             15,063                        
Common stock warrants exercised, shares         14,000                              
Net Income (Loss) (16,158)                           (16,158)          
Foreign currency translation adjustments (238)                         $ (238)            
Balance at Dec. 31, 2021 25,208                         (385) (267,534)          
Balance (in shares) at Dec. 31, 2021         61,000                              
Balance at Dec. 31, 2021               293,331         $ 34 (623)            
Balance, shares at Dec. 31, 2021       251                                
Conversion of Convertible Securities                       251 (251)              
Sale of common stock, net $ 5,602             5,602                        
Sale of common stock, net, shares         7,000                              
Exercise of stock options, net, shares 0                                      
Issuance of Restricted Shares $ 109             109                        
Stock-based compensation 2,117             2,117                        
Deemed dividend on convertible preferred stock       $ 200               (217) 217              
Issuance of stock from RSUs, net               596                        
Issuance of stock from RSUs, net, share         1,000                              
Issuance of convertible preferred stock in rights offering, net of offering costs, shares                                       154,000
Deemed dividend on convertible preferred stock (217)                                      
Temporary Equity Stock Redemption Period Shares                                       (154,000)
Conversion of convertible preferred stock                       $ 251 $ (251)              
Phant Award 596                                      
Exercise of common stock warrants 1             1                        
Common stock warrants exercised, shares         8,000                              
Net Income (Loss) (28,634)                           (28,634)          
Foreign currency translation adjustments (110)                         (110)            
Balance at Dec. 31, 2022 $ 4,889                           (296,168)          
Balance (in shares) at Dec. 31, 2022 77,000       77,000                              
Balance at Dec. 31, 2022 $ 0             301,790           (733)            
Conversion of Convertible Securities   $ 8,883 $ 13,154     $ 2 $ 1     $ 8,881 $ 13,153         $ (8,883)   $ (13,154)    
Conversion of convertible preferred stock, shares           2,038,000 680,000                 (66,000)   (190,000)    
Sale of common stock, net $ 9,553             9,553                        
Sale of common stock, net, shares         503,000                              
Exercise of stock options, net, shares 0                                      
Stock-based compensation $ 1,331             1,331                        
Issuance of stock from RSUs, net, share         4,000                              
Issuance of convertible preferred stock in rights offering, net of offering costs                                   $ 2,738    
Issuance of Series H Convertible Redeemable Preferred Stock, adjustment to redemption, Amount                                   $ 9,377    
Issuance of convertible preferred stock in rights offering, net of offering costs, shares                               75,000 85,000 175,000    
Deemed dividend on convertible preferred stock (16,987)                                      
Temporary Equity Stock Redemption Period Shares                                 (85,000)      
Conversion of convertible preferred stock   8,883 13,154     $ 2 $ 1     8,881 13,153         $ (8,883)   $ (13,154)    
Stock Issued During Period Value Preferred Stock Warrants   (148) (615)             (148) (615)             $ 1,400    
Proceeds from Issuance of Convertible Preferred Stock $ (0)   (0)                         2,720        
Convertible Preferred Stock, adjustment to redemption value   $ (7,611) $ 9,345             $ (7,611) $ (9,345)         $ 7,610        
Stock Issued During Period, Shares, Conversion of Convertible Securities           2,038,000 680,000                 (66,000)   (190,000)    
Preferred Stock Warrants Exercised 20,000                             3,000        
Exercise of Series H Convertible Redeemable Preferred Stock Warrants $ 1,385                             $ 410        
Paid-in-kind dividend on Series J Convertible Preferred Stock, Shares                               3,000        
Exercise of common stock warrants 114             114                        
Common stock warrants exercised, shares         114,000                              
Net Income (Loss) (20,632)                           (20,632)          
Foreign currency translation adjustments 180                         180            
Balance at Dec. 31, 2023 $ (247)       $ 3                   $ (316,800)          
Balance (in shares) at Dec. 31, 2023 3,416,000       3,416,000                              
Balance at Dec. 31, 2023 $ 2,203             $ 317,103           $ (553)       $ 346    
Temporary Equity Shares Ending Balance at Dec. 31, 2023                               $ 1,857        
Balance, shares at Dec. 31, 2023     5,000                         15,000   5,000    
[1] The intrinsic value calculation does not include negative values. This can occur when the fair market value on the reporting date is less than the exercise price of a grant.